Felsberg Advogados advised ALS Global in its acquisition of the totality of the quotas and shares of 12 companies that form the Investiga and Perception Groups in Brazil and the IRSI Group in the United States. ALS Global is headquartered in Brisbane, Australia and has operations in 65 countries. It operates laboratories, provides testing services for the global mining industry, and provides diagnostic testing and engineering services for the energy, resources, transportation, and infrastructure sector.
Felsberg Advogados acted for ALS Life Sciences Latin America in the acquisition of 100% of the Investiga Group of companies (with operations in Brazil, Argentina, Peru, the U.S. and Australia), a pharmaceutical testing business which provides quality control services for food, drugs, beverages, cosmetics and chemicals. Our scope of work encompassed the structuring of the transaction, from corporate and tax standpoints, as well as drafting and negotiating the transaction documents.
“This is an important transaction for our client as it will consolidate the position of ALS in Brazil and Latin America,” says Miriam Machado, the Corporate and M&A partner at Felsberg Advogados who led the team advising ALS. The Felsberg team includes Mirella Kaufman, M&A senior associate; Paula Sozzi, M&A associate; and Juliana Ferreira, M&A associate.